Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
International Clinical Psychopharmacology|May 10, 2024
Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting systemSabrina Wong, Gia Han Le, Angela T H Kwan, et al.
Drug Metabolism Reviews|April 24, 2024
Effects of cannabidiol and Δ9-tetrahydrocannabinol on cytochrome P450 enzymes: a systematic reviewSarah Ann Smith, Gia Han Le, Kayla M Teopiz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 9, 2025
Extracellular vesicles in mood disorders: A systematic review of human studiesCristian-Daniel Llach, Gia Han Le, Sebastian Badulescu, et al.
Therapeutic Advances in Psychopharmacology|December 25, 2025
Effects of glucagon-like peptide-1 receptor agonists on psychiatric disorders: a systematic reviewSerene Lee, Liyang Yin, Kayla M Teopiz, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 6, 2024
Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysisSebastian Badulescu, Gia Han Le, Sabrina Wong, et al.
Journal of Affective Disorders|December 16, 2025
Effects of lithium therapy on blood glucose and insulin levels in individuals with bipolar disorder: A systematic reviewDavid Kanter-Eivin, Konstantin Blinkov, Sadie MacDonald, et al.
Expert Opinion on Therapeutic Targets|April 29, 2025
The sigma-1 receptor: a mechanistically-informed therapeutic target for antidepressantsNaomi Xiao, Liyang Yin, Kayla M Teopiz, et al.
Journal of Affective Disorders|January 20, 2024
A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic reviewSabrina Wong, Angela T H Kwan, Kayla M Teopiz, et al.
Pageof 11